Skip to content

Blind Versus Targeted Epidural Patch With Autologous Platelet-rich Plasma for Spontaneous Intracranial Hypotension

Two-site Blind Epidural Patch Versus Targeted Epidural Patch With Autologous Platelet-rich Plasma for Spontaneous Intracranial Hypotension: A Prospective, Assessor Blind, Randomized, Controlled, Noninferiority Trial

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07283536
Enrollment
0
Registered
2025-12-16
Start date
2025-12-20
Completion date
2026-12-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous Intracranial Hypotension

Brief summary

Spontaneous intracranial hypotension (SIH) is a condition characterized by refractory orthostatic headache, mostly due to loss of cerebrospinal fluid (CSF). Epidural patch with autologous platelet-rich plasma (PRP), which contains numerous growth factors and cytokines, has been reported as a successful alternative for whole blood in dura repair. However, there is no report regarding the best approach to use: targeted epidural PRP patch (TEPP) versus blind epidural PRP patch (BEPP). Preliminary work has suggested that both targeted and blind approaches are effective when using whole blood for epidural patch. Furthermore, two-site blind approach could be considered as a viable initial treatment regardless of the identification of the leak for conventional targeted approach. In this study, the investigators aimed to investigate the non-inferiority of two-site BEPP compared with TEPP for the treatment of refractory SIH cases failing in conservative therapy.

Interventions

PROCEDURETargeted epidural PRP patch

Each patient was subjected to either magnetic resonance myelography (MRM) or/and computed tomography myelography (CTM) to detect the location of CSF leaking. PRP was prepared with the 2-stage centrifugation method and a standard epidural puncture was conducted at the definitive CSF leak locations under the guidance of CT. A predetermined volume of PRP (no more than 10 mL) was titrated slowly into the epidural space for each level. A strict bed stay for 48 h was prescribed in supine position postoperatively.

PROCEDUREBlind epidural PRP patch

PRP was prepared with the 2-stage centrifugation method and the investigators chose two separate sites for epidural access, the C7-T1 and L4-5 levels. A standard epidural puncture was conducted under the guidance of CT. A predetermined volume of PRP (no more than 10 mL) was titrated slowly into the epidural space for each level. A strict bed stay for 48 h was prescribed in supine position postoperatively.

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Informed consent to participate the research obtained from the patient. 2. Age 18-65 years. 3. Satisfies the criteria for SIH according to the International Classification of Headache Disorders criteria for headaches attributed to spontaneous (or idiopathic) low CSF pressure. 4. Failed conservative management (bed rest oral or intravenous hydration, and analgesics) lasting at least 2 weeks.

Exclusion criteria

1. There was concern for other causes of intracranial hypotension, such as postdural puncture, postsurgical and post-traumatic CSF leaks. 2. Prior treatment with EBP at any time previously. 3. Any contraindication to epidural puncture, such as space-occupying intracranial or intraspinal lesions, spinal defect, suspected infection over the puncture site, bleeding disorder and current anticoagulation therapy. History of drug and alcohol abuse, cognitive dysfunction, or mental illness. 4. Unable to comprehend the pain NRS. 5. Unable to cooperate with postoperative treatment, rehabilitation, and follow-up visits.

Design outcomes

Primary

MeasureTime frameDescription
Pain NRS of orthostatic headache48 hours following epidural patch with PRPPain intensity was evaluated by pain numeric rating scale (NRS; 0 = no pain, 10 = unbearable pain) for headache.

Secondary

MeasureTime frameDescription
Pain NRS of orthostatic headache1, 3 and 6 months following epidural patch with PRPPain intensity was evaluated by pain numeric rating scale (NRS; 0 = no pain, 10 = unbearable pain) for orthostatic headache .
The complete relief rate of epidural patch with PRP48 hours, 1, 3 and 6 months after the initial targeted or blind patchThe complete relief was defined as the pain intensity of 0-1/10 on NRS or/and minimal symptoms post-procedurally.
The good response rate of epidural patch with PRP48 hours, 1, 3 and 6 months post-procedurallyGood response was defined as a headache reduction of at least 50%, with improvement of orthostatic component post-procedurally.
The failure rate of epidural patch with PRP48 hours following the initial epidural patch with PRPFailure was defined as a persistent or worsening symptom with less than 50% of headache reduction within 48 hours following the initial epidural patch with PRP
The recurrence rate in each group.During the 6-month follow upRecurrence was defined as fresh onset of headaches beyond the 72-hour mark.
Patients' overall satisfaction6 months following the first epidural patch with PRPPatients' overall satisfaction was graded into very unsatisfactory (1), unsatisfactory (2), neutral (3), satisfactory (4) and very satisfactory (5), according to the Likert scale.
The occurrence of complicationsDuring and after the epidural patch with PRP until the end of 6-month follow up
The percent of patients requiring repeat epidural PRP patchDuring the 6- month follow up

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026